about
Mirtazapine versus other antidepressive agents for depressionMirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedsideApplication of cross-species PET imaging to assess neurotransmitter release in brainRandomized Controlled Trials of Add-On Antidepressants in SchizophreniaMirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depressionMirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson's disease.Pharmacological approaches to methamphetamine dependence: a focused review.Treatment of depression as part of end-of-life care.Monoamine reuptake inhibitors in Parkinson's disease.Repeated mirtazapine nullifies the maintenance of previously established methamphetamine-induced conditioned place preference in rats.A Trilogy Case Review Highlighting the Clinical and Pharmacologic Applications of Mirtazapine in Reducing Polypharmacy for Anxiety, Agitation, Insomnia, Depression, and Sexual DysfunctionContext-dependent effects of a single administration of mirtazapine on the expression of methamphetamine-induced conditioned place preference.COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL.Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram.Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice.GABAergic control of depression-related brain statesOptimizing the Pharmacologic Treatment of Insomnia: Current Status and Future HorizonsEfficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan.Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neuronsMirtazapine overdose is unlikely to cause major toxicity.A review of therapeutic uses of mirtazapine in psychiatric and medical conditions.Pharmacological treatment of obsessive-compulsive disorderHypertensive urgency after administration of a single low dose of mirtazapine-a case report.alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trialA Rapid and Sensitive HPLC-Fluorescence Method for Determination of Mirtazapine and Its two Major Metabolites in Human PlasmaAntidepressant and Antipsychotic Drugs.
P2860
Q24234046-0C4D90BB-6FFA-4478-944E-DEB87B3A7B4EQ24622161-DF679ACB-B0DA-4894-94B1-0C22B9930198Q26865012-68C436B1-E111-4124-B88B-40AADFA48812Q28080437-E29E0F95-3823-48FC-918F-C82EAFFE59F1Q30495433-D2B90AC3-3B68-4F81-A3B3-DAA0DAD1E717Q33826463-C1609100-75FF-4EEF-9554-0A53D22774B2Q33906303-F27A50D2-7F1D-4C73-AA77-089B3ABF4227Q35074983-8C33B1D0-8A55-4309-9B3F-882C8DE5FE9BQ35165280-EDC272E8-0514-4213-AAF2-08B08BFCA106Q35206777-5B92E2DE-34F7-4830-BAAA-95EF6ADF2007Q35688375-59160F11-896A-41CD-9280-F4CE43AEB142Q35747260-0A2535ED-A462-4D97-9673-433A3D26405CQ35889371-069B5EB3-910E-4FFB-9384-E5F4EBAFE601Q36439975-F156E850-5E0B-46BC-A934-96D54684D8B0Q36501038-3D1E4DC4-D71C-4B50-AE12-C1AFA12CF6CFQ36668325-5AAB5A50-D7EE-4867-95FC-81D419662C44Q37149325-D8285C0A-0940-4650-B60D-F9F6E1A973E0Q37182478-89B31FB0-EEF9-4E61-8D17-014AE1DEABEEQ37236791-0AC0CC14-0ADA-483F-A597-7572D1E408F2Q37489869-1A6E630B-6DF7-4959-A10D-1C805787CEC3Q37533880-7CE47745-142A-4A11-81FF-E807EA05218FQ38242548-8FE456FC-36D9-4016-ABA4-C2F98E221CC3Q39756086-4201ECB9-4DDD-4F17-8A16-D55269C90E55Q40884510-EC221DCB-24BD-4AAE-B786-0CA003D88D1CQ41502047-C2602467-71ED-4FD3-8EA2-843C53C2D2C8Q41973647-56EBB210-A324-4749-924D-4FC2D500D2DCQ42018725-3E19382E-8A6F-434E-A587-FFA9980DDEFF
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
The pharmacologic profile of mirtazapine.
@ast
The pharmacologic profile of mirtazapine.
@en
The pharmacologic profile of mirtazapine.
@nl
type
label
The pharmacologic profile of mirtazapine.
@ast
The pharmacologic profile of mirtazapine.
@en
The pharmacologic profile of mirtazapine.
@nl
prefLabel
The pharmacologic profile of mirtazapine.
@ast
The pharmacologic profile of mirtazapine.
@en
The pharmacologic profile of mirtazapine.
@nl
P1476
The pharmacologic profile of mirtazapine.
@en
P2093
P478
57 Suppl 4
P577
1996-01-01T00:00:00Z